Christopher G. Nasveschuk

Person

Stoneham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Spirocyclic compounds
- Patent number 12,227,504
- Issue date Feb 18, 2025
- C4 Therepeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N/O-linked degrons and degronimers for protein degradation
- Patent number 12,180,225
- Issue date Dec 31, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 12,157,735
- Issue date Dec 3, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic fluorine substituted indole derivatives
- Patent number 12,152,041
- Issue date Nov 26, 2024
- The Broad Institute, Inc.
- Steven James Ferrara
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 12,076,405
- Issue date Sep 3, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 12,049,464
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 12,048,748
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted piperidine Degronimers for Target Protein degradation
- Patent number 12,048,747
- Issue date Jul 30, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 11,992,531
- Issue date May 28, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted macrocyclic indole derivatives
- Patent number 11,891,404
- Issue date Feb 6, 2024
- Bayer Aktiengesellschaft
- Kai Thede
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon binders for the degradation of ikaros
- Patent number 11,753,397
- Issue date Sep 12, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 11,691,972
- Issue date Jul 4, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone and indazole compounds for the degradation of EGFR
- Patent number 11,673,902
- Issue date Jun 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic compounds
- Patent number 11,623,929
- Issue date Apr 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic compounds
- Patent number 11,584,748
- Issue date Feb 21, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degraders and Degrons for targeted protein degradation
- Patent number 11,524,949
- Issue date Dec 13, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic indole derivatives
- Patent number 11,492,358
- Issue date Nov 8, 2022
- The Broad Institute, Inc.
- Sarah Anna Liesa Johannes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic chlorine substituted indole derivatives
- Patent number 11,478,451
- Issue date Oct 25, 2022
- Bayer Aktiengesellschaft
- Kai Thede
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N/O-linked Degrons and Degronimers for protein degradation
- Patent number 11,459,335
- Issue date Oct 4, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic chlorine substituted indole derivatives
- Patent number 11,447,504
- Issue date Sep 20, 2022
- Bayer Aktiengesellschaft
- Kai Thede
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted macrocyclic indole derivatives
- Patent number 11,440,923
- Issue date Sep 13, 2022
- Kai Thede
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic indole derivatives
- Patent number 11,401,278
- Issue date Aug 2, 2022
- The Broad Institute, Inc.
- Laura Furst
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic fluorine substituted indole derivatives
- Patent number 11,286,263
- Issue date Mar 29, 2022
- The Broad Institute, Inc.
- Steven James Ferrara
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 11,185,592
- Issue date Nov 30, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic indole derivatives
- Patent number 10,981,932
- Issue date Apr 20, 2021
- Bayer Aktiengesellschaft
- Sarah Anna Liesa Johannes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,905,768
- Issue date Feb 2, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 10,849,982
- Issue date Dec 1, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 10,660,968
- Issue date May 26, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,646,575
- Issue date May 12, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and uses thereof
- Patent number 10,358,437
- Issue date Jul 23, 2019
- Genentech, Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20250127903
- Publication date Apr 24, 2025
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20250121069
- Publication date Apr 17, 2025
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2
- Publication number 20250121070
- Publication date Apr 17, 2025
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS
- Publication number 20250122179
- Publication date Apr 17, 2025
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF
- Publication number 20250115580
- Publication date Apr 10, 2025
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION
- Publication number 20250101037
- Publication date Mar 27, 2025
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20250084081
- Publication date Mar 13, 2025
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20250057957
- Publication date Feb 20, 2025
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS
- Publication number 20250018046
- Publication date Jan 16, 2025
- Biogen MA Inc.
- Kevin M. Guckian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...
- Publication number 20240398959
- Publication date Dec 5, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof
- Publication number 20240383886
- Publication date Nov 21, 2024
- Calico Life Sciences LLC
- Gesine Kerstin Veits
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS
- Publication number 20240343733
- Publication date Oct 17, 2024
- Biogen MA Inc.
- Kevin M. Guckian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTED COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20240245677
- Publication date Jul 25, 2024
- C4 Therapeutics, Inc.
- Katrina L. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
- Publication number 20240158418
- Publication date May 16, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20240076300
- Publication date Mar 7, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20240051953
- Publication date Feb 15, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY
- Publication number 20240018118
- Publication date Jan 18, 2024
- C 4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC COMPOUNDS
- Publication number 20240018156
- Publication date Jan 18, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC COMPOUNDS
- Publication number 20230416251
- Publication date Dec 28, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...
- Publication number 20230372496
- Publication date Nov 23, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20230357180
- Publication date Nov 9, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4
- Publication number 20230339902
- Publication date Oct 26, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N/O-Linked Degrons and Degronimers for Protein Degradation
- Publication number 20230279023
- Publication date Sep 7, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Application
BRAF DEGRADERS
- Publication number 20230145336
- Publication date May 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES
- Publication number 20230112244
- Publication date Apr 13, 2023
- Bayer Aktiengesellschaft
- Kai Thede
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20230110648
- Publication date Apr 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230095223
- Publication date Mar 30, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20230060334
- Publication date Mar 2, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230014124
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT
- Publication number 20230019060
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY

Christopher G. Nasveschuk

Person

Patents Grantslast 30 patents

Spirocyclic compounds

N/O-linked degrons and degronimers for protein degradation

Compounds for targeted degradation of BRD9

Macrocyclic fluorine substituted indole derivatives

Heterocyclic degronimers for target protein degradation

Compounds for targeted degradation of BRD9

Spirocyclic degronimers for target protein degradation

Substituted piperidine Degronimers for Target Protein degradation

C3-carbon linked glutarimide degronimers for target protein degrada...

Substituted macrocyclic indole derivatives

Cereblon binders for the degradation of ikaros

Compounds for targeted degradation of BRD9

Isoindolinone and indazole compounds for the degradation of EGFR

Spirocyclic compounds

Spirocyclic compounds

Degraders and Degrons for targeted protein degradation

Macrocyclic indole derivatives

Macrocyclic chlorine substituted indole derivatives

N/O-linked Degrons and Degronimers for protein degradation

Macrocyclic chlorine substituted indole derivatives

Substituted macrocyclic indole derivatives

Macrocyclic indole derivatives

Macrocyclic fluorine substituted indole derivatives

Spirocyclic degronimers for target protein degradation

Macrocyclic indole derivatives

Heterocyclic degronimers for target protein degradation

C3-carbon linked glutarimide degronimers for target protein degrada...

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

Therapeutic compounds and uses thereof

Patents Applicationslast 30 patents

SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2

BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS

THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF

N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...

Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof

COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS

SELECTED COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY

SPIROCYCLIC COMPOUNDS

SPIROCYCLIC COMPOUNDS

TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...

DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION

TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4

N/O-Linked Degrons and Degronimers for Protein Degradation

BRAF DEGRADERS

SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT